Cited by 328Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research

Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity

Open access
Victor, Matheus B., Leary, Noelle, Luna, Xochitl, Meharena, Hiruy S., Scannail, Aine Ni, Bozzelli, P. Lorenzo, Samaan, George, Murdock, Mitchell H. +8 more·2022·Cell Stem Cell

Published version of a preprint

Abstract

Apolipoprotein E4 (APOE4) is the greatest known genetic risk factor for developing sporadic Alzheimer's disease. How the interaction of APOE4 microglia with neurons differs from microglia expressing the disease-neutral APOE3 allele remains unknown. Here, we employ CRISPR-edited induced pluripotent stem cells (iPSCs) to dissect the impact of APOE4 in neuron-microglia communication. Our results reveal that APOE4 induces a lipid-accumulated state that renders microglia weakly responsive to neuronal activity. By examining the transcriptional signatures of APOE3 versus APOE4 microglia in response to neuronal conditioned media, we established that neuronal cues differentially induce a lipogenic program in APOE4 microglia that exacerbates pro-inflammatory signals. Through decreased uptake of extracellular fatty acids and lipoproteins, we identified that APOE4 microglia disrupts the coordinated activity of neuronal ensembles. These findings suggest that abnormal neuronal network-level disturbances observed in Alzheimer's disease patients harboring APOE4 may in part be triggered by impairment in lipid homeostasis in non-neuronal cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stem.2022.07.005

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • APOE4-associated glial LD accumulation modulates neuron function and brain memory.

    “and the APOE4-associated glial LD accumulation modulates neuron function and brain memory17–19.”

    From PICALM Alzheimer’s risk allele causes aberrant lipid droplets in microglia (2025) · cites this paper as [18]

    The Results sections on microglial energetics and lipid-content modulation report increased lipid droplets in APOE4 microglia and show that their conditioned media reduced neuronal bursts; reducing the droplets preserved neuronal activity. The Discussion section on neuronal excitability only proposes a possible detriment to neural computations critical for learning and memory. It does not establish an effect on memory itself. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • LDAM have sustained activation, impaired phagocytosis and surveillance, and autophagy dysregulation.

    “Among these subsets, LDAM have been given much attention due to their sustained activation, impaired phagocytosis and surveillance, and autophagy dysregulation [26–28].”

    From HIV-TAT dysregulates microglial lipid metabolism through SREBP2/miR-124 axis: Implication of lipid droplet accumulation microglia in NeuroHIV (2025) · cites this paper as [27]

    The Discussion (page unavailable) describes LDAM as having reduced phagocytosis and increased secretion of pro-inflammatory cytokines, supporting part of the claim. The Results (page unavailable) link impaired homeostatic surveillance to lipid accumulation in APOE4-derived microglia, but do not establish that finding for LDAM. The passages do not support sustained activation or autophagy dysregulation in LDAM. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Recent studies on human induced pluripotent stem cells with the APOE4 variant showed altered transcriptomic and metabolomic profiles toward the accumulation of cholesterol in glia, such as astrocytes and oligodendrocytes.

    “Recent studies on human induced pluripotent stem cells (iPSCs) with the APOE4 variant showed altered transcriptomic and metabolomic profiles toward the accumulation of cholesterol in glia, such as astrocytes and oligodendrocytes.5”

    From ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes (2023) · cites this paper as [6]

    The Results section, “Imbalance in the net flux of lipids by APOE4 iMGLs” (page unavailable), reports transcriptional profiling and increased extracellular cholesterol in APOE4 iPSC-derived microglia. The Discussion section, “Cholesterol homeostasis” (page unavailable), reports prior findings of extracellular cholesterol accumulation in APOE4 iPSC-derived astrocytes. The cited paper does not report this finding for oligodendrocytes or describe the claimed metabolomic profiling. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Many LOAD risk-associated genes, such as APOE4, TREM2, and PICALM, have been implicated in regulating microglial immunity and lipid metabolism.

    “Many LOAD risk‐associated genes, such as Apolipoprotein E4 (APOE4), 9 , 10 Triggering receptor expressed on myeloid cells 2 (TREM2), 11 and Phosphatidylinositol‑binding clathrin assembly protein (PICALM), 12 have been implicated in regulating microglial immunity and lipid metabolism, 13”

    From Aberrant phase separation from a rare <i>ABI3</i> mutation drives microglial dysfunction and Alzheimer's risk (2026) · cites this paper as [9]

    The Results (page not provided) link APOE4 to altered microglial lipid processing and a pro-inflammatory state, supporting that example. The paper’s reference list mentions a TREM2–APOE pathway, but the passages do not establish the claim for PICALM; the cited paper therefore supports only part of the gene list. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Treating iMGs with triacsin C effectively decreased BODIPY-labelled LDs.

    “Treating iMGs with triacsin C (TrC), an inhibitor of long-chain acyl-CoA synthetase that reduces LD formation10,18,19,39,40, effectively decreased BODIPY-labelled LDs (Extended Data Fig. 7e–i).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Monif M, Reid CA, Powell KL, Smart ML, and Williams DA (2009). The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J. Neurosci. 29, 3781– 3791. 19321774 PMC6665035

Cited by

Sorted by citations

Authors
Victor, M. B., Leary, N., Luna, X., Meharena, H. S., Scannail, A. N., Bozzelli, P. L., Samaan, G., Murdock, M. H., von Maydell, D., Effenberger, A. H., Cerit, O., Wen, H.-L., Liu, L., Welch, G., Bonner, M., & Tsai, L.-H.
Affiliations
  • Massachusetts Institute of Technology (US)
  • Broad Institute (US)
Corresponding author
Tsai, Li-Huei
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2022-08
Volume
29
Issue
8
Pages
1197-1212.e8
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W4289793560
Cited by
316
References
137
Citations by year
2026: 81 · 2025: 105 · 2024: 73 · 2023: 43 · 2022: 13
FWCI
21.50
Type
journal article
Language
en
Open access
Locations
  • Cell stem cell (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Institutes of Health (AG058002)
  • National Institute on Aging (R01AG058002, RF1AG062377)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
APOE ε4, APOE3, Alzheimer's disease, microglia, lipid accumulation, neuron-microglia communication, neuronal network activity, pro-inflammatory signaling, lipoprotein uptake, lipid homeostasis, induced pluripotent stem cells, CRISPR gene editing
MeSH terms
Alzheimer Disease, Humans, Neurons, Microglia, Apolipoprotein E3, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review